Intervening on Opioid Use and Loneliness
Purpose
This study aims to enroll 300 participants who will be assigned to one of three 3 groups. Each group will receive an intervention lasting 6, weekly sessions of 40-60 minutes. Eligibility include having an opioid use disorder and reporting loneliness or feeling alone or disconnected.
Conditions
- Opioid Use Disorder
- Loneliness
- Social Isolation
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Must be 18+ - understand English -have internet access- - screen positive for an opioid use disorder - screen positive for elevated loneliness
Exclusion Criteria
- does not understand consent - does not have consistent access to a phone and internet
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- Double (Investigator, Outcomes Assessor)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Cognitive-Behavioral Therapy |
CBT delivered over the course of 6, ~45 minute sessions delivered via telehealth |
|
|
Active Comparator therapist-delivered Health Education |
Health education sessions delivered over the course of 6, ~45 minute sessions delivered via telehealth. |
|
|
Active Comparator self-guided Health Education |
Health education sessions that are self-guided over the course of 6 sessions |
|
Recruiting Locations
Rochester 5134086, New York 5128638 14642
Lisham Ashrafioun, PhD
585-430-2026
More Details
- Status
- Recruiting
- Sponsor
- University of Rochester
Detailed Description
Individuals (n = 300) with an opioid use disorder reporting loneliness will be randomized to either (1) therapist-delivered cognitive-behavioral therapy for perceived social isolation, (2) therapist-delivered Health Education, or (3) self-guided Health Education. Loneliness, opioid and other substance use, the amount of social interactions, social support, and mental and physical health factors prior to starting the treatment, after completing the treatment, and 1, 3, and 6 months following the treatment will be assessed to see how well they work compared to each other.